Gene expression data is widely used in various post genomic analyses. The data is often probed using microarrays due to their ability to simultaneously measure the expressions of thousands of genes. The expression data, however, contains significant numbers of missing values, which can impact on subsequent biological analysis. To minimize the impact of these missing values, several imputation algorithms including Collateral Missing Value Estimation (CMVE), Bayesian Principal Component Analysis (BPCA), Least Square Impute (LSImpute), Local Least Square Impute (LLSImpute), and K-Nearest Neighbour (KNN) have been proposed. These algorithms, however, exploit either only the global or local correlation structure of the data, which normally can lead to higher estimation errors. This paper presents an Ameliorative Missing Value Imputation (AMVI) technique which has ability to exploit global/local and positive/negative correlations in a given dataset by automatic selection of the optimal number of predictor genes k using a wrapper non-parametric method based on Monte Carlo simulations. The AMVI technique has CMVE strategy at its core because CMVE has demonstrated improved performance compared to both low variance methods like BPCA, LLSImpute, and high variance methods such as KNN and ZeroImpute, as CMVE exploits positive/negative correlations. The performance of AMVI is compared with CMVE, BPCA, LLSImpute, and KNN by randomly removing between 1% and 15% missing values in eight different ovarian, breast cancer and yeast datasets. Together with the standard NRMS error metric, the True Positive (TP) rate of the significant genes selection, biological significance of the selected genes and the statistical significance test results are presented to investigate the impact of missing values on subsequent biological analysis. The enhanced performance of AMVI was demonstrated by its lower NRMS error, improved TP rate, bio significance of the selected genes and statistical significance test results, when compared with the aforementioned imputation methods across all the datasets. The results show that AMVI adapted to the latent correlation structure of the data and proved to be an effective and robust approach compared with the trial and error methodology for selecting k. The results confirmed that AMVI can be successfully applied to accurately impute missing values prior to any microarray data analysis.
Introduction
Microarrays gene expression data are used in a wide range of biological applications from the study of human tumours [1, 2] to yeast sporulation [3] because of their ability to measure the gene expressions for many thousands of genes under a variety of conditions. This expression data are subsequently applied in a range of applications from diagnosis to drug discovery [4] , all of which to some degree involve analysis using stochastic, mathematical and machine learning methods [5] [6] [7] such as, class prediction [9, 10] , clustering [11] , gene regulatory network reconstruction [12] , and data dimension reduction [8] . Despite wide usage, microarray data frequently contain at least 5% missing values and in most datasets, at least 60% of genes have one or more missing values [13] . Once microarray images have been scanned, the problematic spots are identified as missing values with the reason for such occurrences include slide scratches, spotting problems, blemishes on the chip, hybridization error, image corruption or simply dust on the slide [14] . Sometimes for instance, a background color has a higher intensity than a foreground color due to bleeding from neighboring spots, while background subtraction may also produce negative values which are subsequently marked as missing. It is important to highlight that the definition of missing values used in this paper is different from the present/absent flag in GeneChip data (Affymetrix software), which indicates whether or not genes are detectable at significant levels [15] .
As previously alluded to, the missing values can seriously impact upon subsequent data analysis involving for example, significant class prediction, gene selection, gene regulatory network reconstruction [16] and clustering algorithms such as Support Vector Machines (SVM), Neural Networks (NN), t-test [17] , and Hierarchical Clustering [18, 19] . Several approaches to impute missing values have been proposed with the simplest being either the repetition of the experiment, though this is often not feasible for economic reasons or ignoring samples containing missing values, but again this is not recommended because there may only be a limited number of samples available. Other alternatives include, row average/median impute (replacement by the corresponding row average/median) and zero impute (replace the missing values by zero) though these are high variance approaches as neither takes advantage of inherent data correlations, so leading to higher estimation errors [20] . A rational strategy is to accurately estimate the missing values, since if the latent correlations in the data are exploited then the missing value prediction errors will be significantly reduced [18, 21, 22] . This has been the catalyst for a myriad of imputation techniques including Collateral Missing Value Imputation (CMVE) [23] , K-Nearest Neighbor (KNN), Least Square Imputation (LSImpute) [22] , Local LSImpute (LLSImpute) [10] and Bayesian PCA (BPCA) [14] . The resulting estimation errors can still be high, as certain algorithms chiefly focus only on global correlation (BPCA), while others exploit local correlations in the data structure (KNN) by using a fixed number of predictor genes. This provided the motivation for the development of new generic techniques that minimize prediction errors by optimizing the number of predictor genes. In addition, traditionally the comparative imputation performances of CMVE, BPCA, LSImpute, LLSImpute, and KNN have been evaluated using a Normalized Root Mean Square (NRMS) error measure, which does not fully elucidate the impact of estimation on any subsequent analysis like significant gene selection where a biological interpretation of different genes for different diseases is mandated. So a more rigorous analysis of each gene affected by the missing values is required. This paper presents Ameliorative Missing Value Imputation (AMVI) algorithm that employs a combination of correlated genes to estimate missing values by multiple imputation matrices. The basis of AMVI is the CMVE technique that has proven both theoretically and empirically [23] to be a better estimator compared with established algorithms such as KNN, LLSImpute and BPCA. Like KNN, however, CMVE does not automatically determine the optimal number of predictor genes k from the dataset, which can lead to higher estimation errors. For data with a local correlation structure, if a large k-value is used then it may include genes which have no correlation with the gene that has missing values. Similarly, if data has a global correlation structure, then a small value of k ignores correlated genes in the prediction, again resulting in a higher estimation error, so it is highly desirable to calculate the best value of k based upon the underlying correlation structure of the data. LLSImpute automatically determines k, though since this method is based on LS regression it provides coarser estimates and manifests in higher imputation errors. AMVI uses CMVE at its core and incorporates a wrapper nonparametric estimator based on Monte Carlo simulations [24] to automatically determine k, thereby combining the intrinsic benefits of CMVE with a strategy to automatically estimate the optimal number of predictor genes, as by LLSImpute. The reason to use this particular strategy to estimate k is explained in Section 3.
The estimation performance of AMVI has been rigorously tested and compared with the aforementioned wellestablished and recently proposed, imputation techniques, namely CMVE, KNN, LLSImpute, and BPCA in predicting randomly introduced missing values with probabilities ranging from 0.01 to 0.15 for eight different ovarian, breast cancer [3, 25, 26] , and yeast saccharomyces cerevisiae datasets [27] . In particular, the study compared the impact of estimation on significant gene selection using Between Sum of Squares to Within Sum of Squares (BSS/WSS) method, where AMVI demonstrated enhanced gene selection capability for breast and ovarian cancer (Homo sapiens), and yeast (simple eukaryote) datasets. The biological analysis of the selected gene demonstrated that the AMVI selected many important expressed genes, which were ignored by the other imputation methods. In addition, the results were cross validated using non-parametric Wilcoxon Ranksum Significance test [28] , where the results again, mandated the improved performance of AMVI. For completeness, results were also compared using the standard NRMS error [29] metric to quantitatively assess the estimation performance of each imputation method, with results once again demonstrated improved accuracy and robustness of AMVI over a wide range of missing values.
The remainder of the paper is organized as follows: Section 2 briefly reviews the main properties of existing imputation techniques, while details of the new AMVI algorithm and its underlying theory are presented in Section 3. A comprehensive discussion and analysis of the results, including their biological significance is presented in Section 4, with some conclusions are provided in Section 5.
Review of existing imputation techniques
In describing various imputation techniques, the following nomenclature is adopted. Microarray gene expression matrix Y 2 R mÂn contains m genes and n samples. In Y, every gene i is represented by g i , so Y in n experiments is arranged as Y ¼ ½g 1 . . . g m T 2 R mÂn . A missing value in gene i for sample j is expressed as Y ði; jÞ ¼ g i ðjÞ ¼ N.
The following paragraph provides a brief review of the main features of KNN, LLSImpute, BPCA and CMVE, which are the algorithms used in this paper to compare with the performance of AMVI.
KNN [20] estimates missing values by searching for the k nearest genes using the Euclidean distance function and then taking the weighted average. The method, however, does not consider negative correlations [21] and has the disadvantage of using a predetermined value of kregardless of the dataset being used. Kim et al. [30] introduced Least Square (LS) regression based algorithm called LLSImpute that automatically selects the number of estimator genes k using an exhaustive search method. The method has shown to be having lower estimation error than other least square regression based estimation methods, such as LSImpute [30] . The BPCA [14] imputation technique uses Bayesian estimates and Principal Component Analysis to impute the missing values, though this technique only exploits global correlations within the data structure, which can lead to erroneous estimates if data possesses a strong local correlation [14] . The CMVE algorithm developed by Sehgal et al. [23] generates multiple estimation matrices using Non-Negative Least Square (NNLS), Linear Programming (LP) and LS regression techniques to approximate missing values. In spite of its enhanced estimation performance over other algorithms it still relies upon a preset parametric value of k, which ultimately limits its applicability. While LLSImpute automatically determines k, it still has least square regression as its core resulting in higher estimation errors. This initiated a need for a suitable algorithm to automatically determine the best value of k, directly from the correlation structure of the data while concomitantly providing low estimation errors. Next section presents the AMVI estimation technique, which combines both the enhanced estimation capability of CMVE with a new strategy for deriving the optimal value of k directly from the correlation structure of the data.
Non-parametric Ameliorative Missing Value Imputation (AMVI)
The AMVI algorithm, which is formally presented in Fig. 1 , imputes missing values in three stages. Firstly, the number of estimator genes k is computed using a wrapper non-parametric algorithm that exploits the correlation structure of the data. Secondly, the k most correlated genes with gene g i that contains the missing value are selected for a given dataset, and finally g i is approximated using the CMVE kernel with NNLS, LP and LS regression at its core.
To select the number of estimator genes k, a set of vectors v from Y is selected using Monte Carlo Simulation with uniform distribution for the interval [m, n] [24] where a statistical conservative value of selection probability = 0.05 is chosen [31] 
Step 1, Fig. 1 ). This is followed by the selection of genes G which are present in v (Step 2), such as
with these values of G treated as missing values and iteratively estimated for a range of different k values (Step 3). Finally, the k value which produces the minimum NRMS error is designated as the optimal value (optk) and used in the actual estimation of missing value Y ij of gene i and sample j, which involves three estimates U 1 , U 2 and U 3 being generated, and the final estimate v computed by their fusion using CMVE (Method Estimate in Fig. 1 ). To estimate the missing value, for any given data set, the absolute diagonal covariance C is computed using (1) for a gene vector g i , which contains an actual missing value, where every gene except i is iteratively considered as a predictor gene (x) (Step 1.2 Estimate Method). The covariance function C is formally defined as:
Another option would have been to use Pearson Correlation, though the overall effect is exactly same for normally distributed data [32] . The genes are then ordered with respect to their covariance values and the first optk ranked covariate genes R optk are selected, whose expression vectors have the closest similarity to gene i from Y in all samples except j (Step 1.4). The LS regression [33] is then applied to estimate value U 1 ) for Y ij (Step 1.5) as:
where n is the error term that minimizes the variance in the LS model (parameters a and b). For a single regression, the estimate of a and b are, respectively, a
where I xy is the covariance between R optk and g i computed using (1) and
the variance of R optk with R optk ; where g i being the respective means of R optk and g i , The two other missing value estimates U 2 and U 3 (Step 1.6) are, respectively, given by:
where u is the vector that minimizes n 0 in (5), g is the normal residual and n is the actual residual. These three parameters are obtained from the NNLS algorithm [33] . The objective is now to find a linear combination of models that best fit R optk and g i . The objective function in NNLS minimizes the prediction error n 0 using linear programming (LP) techniques, so that:
minðn 0 Þ is a function that locates the normal vector u with minimum prediction error n 0 and residual g. The value of n 0 in (5) is obtained from:
where SV are the singular values of the difference vector between the dot product of R optk and prediction coefficients u with the g i . The tolerance used in the LP to compute vector u is given by:
where optk is the number of predictor genes computed by the Non-parametric algorithm using Monte Carlo simulations, n the number of samples in the dataset and N f is normalization factor. The final estimate v for Y ij is formed by:
where q ¼ D ¼ K ¼ 0:33 ensures an equal weighting to the respective estimates U 1 , U 2 and U 3 , which avoids bias being given towards one particular estimate as each is highly data dependent. The final fused value v has a lower NRMS error as the imputation matrix U 1 uses LS regression, while matrices U 2 and U 3 use Non-Negative LS (NNLS).
Analysis of results and discussion

Test data
To analyze and compare the performance of the proposed AMVI algorithm with CMVE, BPCA, LLSImpute, KNN, and ZeroImpute, eight microarray cancer and yeast datasets from different studies on breast, ovarian cancer tissues and yeast Saccharomyces cerevisiae were used. The rationale for selecting cancer datasets is that generally, cancer data lack molecular homogeneity in tumour tissues, which can result in erroneous results when imputation methods are applied [15] while the choice of yeast data was made due to its wide usage by bioinformatics community. One of the possible reason of the wide usage of yeast data could be due its simplest genome in eukaryotic family (1.2 Â 10 7 base pairs) [34] . The locally correlated breast cancer dataset contained 7, 7, 8 samples of BRCA1, BRCA2, and sporadic mutations (neither BRCA1 nor BRCA2), respectively [26] . The globally correlated ovarian cancer dataset contained 16, 16, and 18 samples of BRCA1, BRCA2, sporadic mutations, respectively [25] . While the yeast data had six samples at different time stamps in each heat shock study. The heat shock response in yeast was measured at 30°C and 60°C. There were 3225, 6445, and 6130 genes in each sample of breast, ovarian and yeast datasets, after the removal of gene expressions with more than 20% missing values.
Analysis of simulation results
This section provides rigorous analysis of empirical results, which includes validation of imputation strategies based on gene selection performance, biological significance of the selected genes, statistical significance test and standard NRMS error.
Gene selection using BSS/WSS
To cross validate the performance of AMVI on gene selection BSS/WSS method was used.
The method identifies those genes which concomitantly have large inter-class variations and small intra-class variations. For any gene i in Y 2 R mÂn , BSS/WSS is calculated as follows:
where T is the training sample size, Q the number of classes and F() is a Boolean function = 1 if the condition is TRUE and zero, otherwise. Y j denotes the average expression level of gene i across all samples and Y qi is the average expression level of gene i across all samples belonging to class q. Genes are then ranked by BSS/WSS ratios, from the highest to the lowest to form a significant gene expression matrix #, where the first p genes are selected for subsequent class prediction. To set a benchmark gene set a set of p genes G org was selected from the original data Y using the BSS/WSS method.
To fully test the robustness of the AMVI algorithm, experiments were performed for missing values up to 15%, with values being iteratively removed from the original gene expression matrix Y. Missing values were then estimated using KNN, LLSImpute, BPCA, CMVE, and AMVI to form Y est , before respective sets of p genes G s were selected using the BSS/WSS method for each estimated matrix. These selected genes were then compared with G org to compute the True Positive (TP) rate. Fig. 2 plots the TP rate for first 1000 significant genes in breast cancer, from which it is clear that AMVI outperformed all other comparative methods in terms of estimation quality. The localized correlation structure of this dataset is confirmed by the generally lower TP rate for BPCA, which is characterized by exploiting only global correlation performed worse than a high variance method such as KNN. CMVE despite using a fixed number (k = 10) of predictor genes exhibited good performance as it exploited the underlying local correlation structure of the data. cer datasets, with results again highlighting the improved performance of AMVI.
The experimental results on yeast data in Fig. 6 demonstrate that AMVI showed higher TP rate than CMVE, LLSImpute and KNN. Interestingly, BPCA had lower error for higher percentage of missing values than AMVI, though it was not retained for the aforementioned ovarian and breast cancer data (Figs. 2 and 3) . The AMVI, however, inculcation consistently showed acceptable performance for the complete range of missing values in all the datasets which underpins that AMVI can be used to estimate missing values in gene expression data prior to any biological analysis.
As mentioned in Section 1 that it is important to study the selected genes therefore, the study was undertaken on cancer data. For the purposes of clarity, the overall trend of gene selection is shown in Figs. 7 and 8, which both reveal that certain genes are more affected by missing values and the subsequent impact of imputation than others, due to both the location of missing values and differing variances. For example, Gene ID 28 in Fig. 7 has a low TP rate being selected only 17 times out of 42 (40% selection rate) by all imputation techniques other than AMVI, which had a success rate for this particular gene of 100% (Fig. 4) compared to 57%, 57%, 28%, 0%, and 0% for CMVE, LLSImpute, BPCA, KNN and ZeroImpute, respectively (Fig. 4) . Similarly, Gene 6 in Fig. 8 has selection rate of only 38% and yet was always correctly selected by AMVI (Fig. 5 ) due to its better estimation ability. The same gene had respective TP rates of 57%, 43%, 29%, 14% and 0% for LLSImpute, BPCA, LSImpute, CMVE and KNN (Fig. 5 ).
Biological significance of selected genes
In examining different datasets, AMVI identified a number of genes overlooked by all the other algorithms [35] , which alter expressions in tumor lines and so could be important in oncogenesis. This set of genes has not only been selected by BSS/WSS algorithm but has been revalidated using the modified t-test with greedy pairs method [36] . The revalidation minimizes the bias of the gene selection strategy towards either a particular imputation technique or a set of genes.
For example, as the results in Table 1 reveal, the KIAA1025 protein was not selected when values were imputed using KNN, LLSImpute, BPCA, CMVE and ZeroImpute, but had been identified when gene selection was preceded by AMVI imputation. This is an important protein which is co-regulated with estrogen receptors for both in vivo and clinical data, and is expressed in more than 66% of human breast tumors [37] . Another gene selected by AMVI across the range of missing values is plakophilin 2 (PKP2) which is a common protein and exhibits a dual role, appearing as both a constitutive karyoplasmic protein and a desmosomal plaque component for all the desmo- some-possessing tissues and cell culture lines. The gene is found in breast carcinoma cell lines [38] and furthermore, because of its significance it can serve as a marker for the identification and characterisation of carcinomas derived either from or corresponding, to simple or complex epithelia [39] (see Table 1 ). Similar observations can be made in the study of significant genes in the ovarian cancer dataset. For instance, MHC Class II = DQ alpha (MHCa) and MHC Class II = DQ beta (MHCb) genes are linked to the immune system and have been shown to be down-regulated for ovary syndrome [40] . Also, the allele gene is present at a higher frequency in patients with malignant melanoma than in Caucasian controls. These genes help in particular to diagnose melanoma patients in the relatively advanced stages of the disease and/or patients who are more likely to have a recurrence [41] . The results reveal that these genes have been correctly identified by AMVI while being consistently missed by other imputation methods, especially for higher numbers of missing values (see Table 2 ).
Significance test
This section provides the results of two-sided Wilcoxon Rank Sum Statistical Significance test. The significance test was undertaken, to prove the validity of the estimation accuracy achieved by different imputation methods, with statistically conservative significance level of 0.05 [28] . The rationale behind using this test was that it does not mandate the data to have equal variances, which is vital given the variances of data can be disturbed due to erroneous estimation, especially in case of ZeroImpute. The null hypothesis H 0 Y Y est where Y and Y est are the actual and estimated matrices, respectively, the P-value of the hypothesis is calculated as:
where y r is the sum of the ranks of observations for Y and R is the corresponding random variable. AMVI demonstrated best performance for all the three cases of breast cancer data (BRCA1, BRCA2 and sporadic). It is noteworthy that the (1 À P) (the null hypothesis rejection probabilities) values are plotted in Figs. 9-11 for the sake of clarity. Therefore, the higher (1 À P) value represents more accurate estimation than lower (1 À P) values. The results were significant for higher percentage of missing values where the comparative methods had higher error rate for large number of missing values. For instance, LLSImpute had varied performances for different range of missing values and could not maintain it for higher percentage of missing values (Figs. 9-11) . Similarly, observed when AMVI and comparative methods were applied to ovarian cancer data (Figs. 12-14 For the sake of completeness, the algorithms were also compared based on the standard NRMS error. The next section provides analysis of NRMS error in detail:
Calculation of normalized root mean square error
The missing value estimation techniques were also evaluated by randomly removing between 1% and 15% values from the datasets and then computing the imputation error in terms of the NRMS error H:
where Y is the original data matrix and Y est is the estimated matrix using AMVI, CMVE, BPCA, LLSImpute, and KNN, respectively. This particular measure has been used by Tuikkala et al. [13] and Sehgal et al. [23, 29] for error estimation because H = 1 for zero imputation.
To compare the performance of CMVE, KNN, BPCA and LLSImpute with AMVI algorithm, k = 10 was used throughout the experiments. As Troyanskaya et al. [20] Significance observed, KNN is insensitive to the values of k in the range 10-20 and the best estimation results are achieved in this interval. Similarly, we used k = 10 for CMVE due to the reason described in [23] . In contrast, LLSImpute determines the value of k using correlation structure of the data, while AMVI automatically determines the optimal value of optk using wrapper non-parametric algorithm (see Fig. 1 ), which exploits the underlying correlation structure of the data due to the reasons underlined in Section 1. The imputation results also revealed some interesting issues. Since, BPCA exploits only global correlation in the data; all other algorithms had a lower NRMS error in the case of the BRCA1, a locally correlated breast cancer data (Fig. 17) , though conversely, when it was used to estimate the missing values for the datasets possessing global correlation structure, it performed better than both KNN and LLSImpute (Fig. 18 ). The performance of AMVI was further evaluated on yeast data where the results again demonstrated that AMVI has lower estimation error rate in terms of NRMS error compared to the aforementioned imputation strategies (Figs. 19 and 20) . As mentioned earlier, it is highly important that estimation methods should be able to demonstrate lower estimation errors across the range of datasets. For instance, BPCA method had lower imputation error for ovarian cancer (Fig. 17) but showed largest disparity for yeast dataset (Fig. 19) . Similarly, LLSImpute exhibited lower NRMS error for cancer datasets but could not maintain the same performance for both yeast datasets (Figs. 19 and 20 ) and the error rate was comparable to KNN. The CMVE (Fig. 17) exhibited lower NRMS error for both types of cancer data; but it did not maintain this performance when determining significant genes in the ovarian cancer data (Fig. 3) due to global correlation structure possessed by the dataset. In contrast, AMVI adapted to the correlation structure of the data and showed improved performance for all types of datasets, so endorsing the strategy to compute the optimal number of predictor genes based on the correlation structure of the data, rather than using a fixed value.
Conclusions
This paper has presented a new Ameliorative Missing Value Imputation (AMVI) algorithm based on the concept of automatic estimation of the optimal number of predictor genes for the fusion of multiple imputation matrices. AMVI has demonstrated a capability to adapt to any type of data correlation, with experimental results including the True Positive rate of significant genes selection, biological significance analysis of the selected genes, statistical significance test and normalized root mean square error, proving this algorithm provided lower estimation error compared with other comparative missing value imputation techniques, namely CMVE, LLSImpute, BPCA, KNN, and ZeroImpute. The impact of this improvement was especially highlighted when significant genes were selected prior to imputation. The reason for this superior performance is that AMVI combines the exploitation of global and local correlations in a given dataset with the automatic selection of the optimal number of predictor genes k by a wrapper non-parametric method based on Monte Carlo simulation. This consistently proved to be an effective and robust strategy compared with the trial and error approaches adopted by CMVE and KNN for selecting k and confirmed that AMVI can be successfully applied to accurately impute missing values prior in any microarray data experiment.
